Nestlé Investor Seminar 2008

Similar documents
An exciting combination in a high growth, high margin Nutrition category. Name of chairman

Welcome to the Nine-Month Sales Conference

Nestlé Dairy s new frontier: healthy ageing

Autumn Press Conference October 2005

Nutrition, Health & Wellness The Nestlé Perspective. Paul Bulcke Chief Executive

Expanding the boundaries of nutrition Luis Cantarell

Straumann s net revenues reach CHF 185 million in Q1, driven by continuing double-digit growth in America

Welcome to the Full -Year Results Press Conference

Value creation through profitable growth Danske Bank Winter Seminar 2017, Copenhagen Lars Rasmussen, President & CEO

ADM to Acquire Neovia and Probiotics International Limited. July 2, 2018

A world leader in allergy immunotherapy

GROWTH NOW! Franck Riboud

A GLOBAL LEADER IN PERSONALIZED NUTRITION

Nestlé Investor Seminar 2007

Value creation through profitable growth Handelsbanken Nordic Large Cap Seminar, Stockholm 2016 Anders Lonning-Skovgaard, CFO

Putting ALK on the right growth trajectory

William Demant. Jefferies Healthcare Conf. Nov Søren B. Andersson, VP Investor Relations

January 30, 2018 Dow Wilson President and Chief Executive Officer

H. LUNDBECK A/S. Teleconference. 10 August PM CET. Financial results Second quarter 2011

TELECONFERENCE FY February 2015

Value growth in Human Nutrition & Health

Myriad Genetics Corporate Presentation 06/13/2018

Genomic Health. Kim Popovits, Chairman, CEO and President

Nordea investor meeting. June 18 th, 2018 Kristian Villumsen, EVP Chronic Care

Roche Diagnostics Daniel O Day COO Roche Diagnostics. Société Générale - The Premium Review Conference, Paris December 2, 2011

Coloplast A/S. Investor presentation 1H 2005/06

Nestlé Health Science Overview

A world leader in allergy immunotherapy. Jefferies Global Healthcare Conference, London : 19 November 2014 : Flemming Pedersen, CFO & EVP

Increase in revenues in line with full-year targets (+1.2%) Very strong growth of Oralair exc. USA (+26%) H revenues and results - 24 July 2014

Developing & Commercializing Targeted Small Molecule Drugs in Cancer

Bank of America Merrill Lynch HealthCare Conference Bayer HealthCare Dr. Jörg Reinhardt. September 14, 2011

Straumann reports 4% growth in local currencies (l.c.) in the first nine months of 2010

TELECONFERENCE Q November 2015

The acquisition of Fortitech

Nutrition Chris Goppelsroeder President & CEO DSM Nutritional Products ROYAL DSM HEALTH NUTRITION MATERIALS

Company presentation. SEB Nordic Seminar Bella Sky, Copenhagen. Carsten Hellmann, President & CEO 9 January 2018

MediCult. DnB NOR 2008 Health Seminar. Life s Beginning in Safe Hands

Welcome to the New York Press Conference

Corporate Update Simon Hubbert, CEO Bill Kullback, CFO June, 2015

Jefferies Healthcare Conference

VITROLIFE AB (PUBL) Pareto Securities Health Care Conference

2015 Investor Conference

Chronic Care Coloplast Meet the Management London 2017 Kristian Villumsen, EVP Chronic Care Edmond Veome, SVP Chronic Care North America

JEFFERIES 2016 HEALTHCARE CONFERENCE. June 2016

Nestlé Nutrition - Helping athletes optimize performance

ST. JUDE MEDICAL / THORATEC TRANSACTION HIGHLIGHTS July 22, 2015

Straumann on track with organic 1 growth of 9% in first 9 months

Coloplast A/S. Investor Presentation 2005/06

TELECONFERENCE Q August 2015

Ipsen Oddo BHF Forum January 12, 2018

The New Danone : A unique food company. Autumn Conference 2008 CA Cheuvreux

Key figures (consolidated)

Food Specialties Patrick Niels President DSM Food Specialties ROYAL DSM HEALTH NUTRITION MATERIALS

Strategic Business Overview. Bernard HOURS

Nomura Healthcare Conference

Walgreen Co. Reports Second Quarter 2010 Earnings Per Diluted Share of 68 Cents; Results Include 2 Cents Per Diluted Share of Restructuring Costs

Jefferies 2014 Global Healthcare Conference November Because people depend on us

Acquisition of Novartis Influenza Vaccines Business. 27 th October 2014

Health for Humanity 2020 Goals 2

Table of Contents. 1. About Solvay Solvay at a Glance Group Portfolio Transforming Solvay Solvay s Portfolio Upgrade 7

GN Store Nord Goldman Sachs European Medtech and Healthcare Services Conference. CEO GN ReSound, Mike van der Wallen September 3, 2008

Corporate Presentation

VITROLIFE AB (PUBL) NORDEA Small & Mid Cap Seminar

Nestlé in the USA & Frozen Meals Performance. February 23, 2017 Jeff Hamilton President Nestlé Food Division Nestlé USA

Global Cosmetic Dentistry Market Research Report 2018

Delivering Results POSITIONED FOR GROWTH. Analyst & Investor Day October 14, 2015 Paul Guggenheim CEO, Patterson Dental

Global Invisible Braces Market: Trends, Opportunities and Forecasts ( )

AstraZeneca to Acquire Bristol- Myers Squibb Share of Global Diabetes Alliance. Becoming Global Leaders In Diabetes

18 June The New Danone : A unique food company

JP Morgan H&Q Healthcare Conference January 7, Shire Pharmaceuticals Group plc

Coloplast A/S. Carnegie Nordic Healthcare Seminar 31 May - 1 June

Coloplast A/S. Goldman Sachs Medtech Conference London, 7-8 September Sten Scheibye, CEO

Global Dental Implant Market Research Report 2018

We improve quality of life by preventing and curing allergy

Continued value growth

36th Annual J.P. Morgan Healthcare Conference. Kevin Conroy, Chairman and CEO January 9, 2018

BRIC Transurethral Resection of the Prostate (TURP) Procedures Outlook to 2020

27 th Annual J.P. Morgan Healthcare Conference. January 13, 2009

Nestlé Investor Seminar 2008

CYCLOTRONS WORLD MARKET REPORT & DIRECTORY EDITION TOC and Summary USED IN NUCLEAR MEDICINE MARKET DATA, COMPANIES PROFILES.

The power of innovation to save lives

Health and nutrition, at the core

Presentation to 2019 JP Morgan Healthcare Conference

Intercell and Novartis form world leading strategic partnership to drive vaccines innovation

Grupo Fleury announces the acquisition of Grupo Papaiz, entering the dental diagnostics market. September 28th, 2012

Universal Biosensors, Inc.

Leading R&D pipeline with proven technology. Partners. Injection and drop-based allergy immunotherapy products

For personal use only

Investor Day EEMA Region Lausanne, September 29, Drago Azinovic President, Eastern Europe, Middle East & Africa Region & PMI Duty Free

Human Nutrition Jeremy Xu President Human Nutritional & Health ROYAL DSM HEALTH NUTRITION MATERIALS

Partnering for Growth

A world leader in allergy immunotherapy

Q Investor Kit JANUARY-JUNE 2014

DIEBOLD NIXDORF AG AT GERMANY EQUITY FORUM

GAVI ALLIANCE: UPDATE AND FUTURE DIRECTIONS FOR GLOBAL VACCINES AND IMMUNISATIONS

To be the partner of choice Straumann

Investor Day LA&C Region Lausanne, September 29, Jeanne Pollès President, Latin America & Canada Region

Country Coverage. Company Coverage

Letter to Shareholders SEMI-ANNUAL REPORT 2008

EU5 Bariatric Surgery Procedures Outlook to 2020

Transcription:

Nestlé Investor Seminar 2008 Nestlé Nutrition update on Acquisitions Richard Laube CEO Nestlé Nutrition 1

Disclaimer This presentation contains forward looking statements which reflect Management s current views and estimates. The forward looking statements involve certain risks and uncertainties that could cause actual results to differ materially from those contained in the forward looking statements. Potential risks and uncertainties include such factors as general economic conditions, foreign exchange fluctuations, competitive product and pricing pressures and regulatory developments. 2

Nestlé Nutrition has doubled its size through organic growth & acquisitions Strategic acquisitions with CHF 4 billion in sales in 2006/2007 Sales in CHF bio 5.3 1.0 0.5 1.2 2.3 10.3 Nestlé Nutrition 2005 Sales growth Nestlé Nutrition 2007 (Q4 annualised) 3

Nestlé Nutrition in 2008: A CHF 11 billion business 17% HealthCare Nutrition 7% Weight Management 3% Performance Nutrition Sales (CHF bn): 11* Business Units: 4 Employees: 20 000 Office locations: 12 73% Infant Nutrition Factories: 30 Technical centres: 5 *estimate, at 2007 closing rates 4

Investor Day June 2007: Nestlé Nutrition objectives Driving innovation: Enhance consumers' lives by providing innovative and superior products & services Deliver 10/20 model: Deliver sustainable organic growth of 10% and EBIT margin of 20% or more Create value from acquisitions: Successful integration of Jenny Craig, Gerber and Novartis Medical Nutrition to accelerate growth Today: Update on progress against our 3 objectives 5

Nestlé Nutrition update June 2008 1. Driving innovation: Enhance consumers' lives by providing innovative and superior products & services 2. Deliver 10/20 model: Deliver sustainable organic growth of 10% and EBIT margin of 20% or more 3. Create value from acquisitions: Successful integration of Jenny Craig, Gerber and Novartis Medical Nutrition to accelerate growth 6

Challenge of Innovation: Unlocking the sweetspot Challenge: How to unlock the sweetspot in a systematic and repeatable way? What is needed by consumers? The sweet spot of innovation What is commercially achievable? What is technically and scientifically possible? 7

The virtuous innovation cycle at Nestlé Nutrition Meeting Consumer Needs Launch tracking & learnings Consumer understanding Idea & Concept Innovation/ Renovation Innovation Cycle Commercialisation Product development Availability Efficiency Industrialisation 8

Infant Formula I/R driving growth since 2005 I/R at Nestlé Nutrition The most important growth driver +CHF 1 200 m + 54% +CHF 800 m + 35% Sales (CHF m) 2 300 3 100 > 3 500 2 400 2 300 2 200 2 300 2 500 2 700 2000 2001 2002 2003 2004 2005 2006 2007 Est. 2008 9

We continue to significantly strengthen our innovation pipeline Incremental NPS Year 3 (CHF mio.) 200 Satellite Champion Evaluation: 100 50 Lucy Lemon Advanced Booster Gold Everest Model T Express Scoop Galaxy Impact Pole Position Pickwick Image removed NAN Sensitive 20 Jupiter Boost Immunity* Rash* Halal Sesame Street Yogurt Melts Competitor sensitive information 10 Zorro Jogolino Lili Entrees New Al 110 Good Start 10 5 % 10 % 15 % 20 % 25 % 30 % 35 % 40 % 45 % 50 % EBIT Margin Year 3 Infant Nutrition Infant Formula Infant Nutrition Meals & Drinks Fruit & cereal bars Lil Crunchies Infant Nutrition Infant Cereals, GUM & CMD Healthcare Nutrition Performance Nutrition Optifast 800 Size of Bubbles reflect relative R&D Resources

Nestlé Nutrition update June 2008 1. Driving innovation: Enhance consumers' lives by providing innovative and superior products & services 2. Deliver 10/20 model: Deliver sustainable organic growth of 10% and EBIT margin of 20% or more 3. Create value from acquisitions: Successful integration of Jenny Craig, Gerber and Novartis Medical Nutrition to accelerate growth 11

Delivering 10/20 model: On track! 2005 2006 2007 2008 Q1 Sales (CHF million) 5 270 5 955 8 434 2 576 Organic growth (%) 5.3 6.1 9.7 14.4 RIG (%) 2.2 2.2 6.5 10.2 EBIT (CHF million) 932 1 005 1 447 > EBIT margins (%) 17.7 16.9 17.2 > 12

Nestlé Nutrition update June 2008 1. Driving innovation: Enhance consumers' lives by providing innovative and superior products & services 2. Deliver 10/20 model: Deliver sustainable organic growth of 10% and EBIT margin of 20% or more 3. Create value from acquisitions: Successful integration of Jenny Craig, Gerber and Novartis Medical Nutrition to accelerate growth 13

Three strategic acquisitions with value creation opportunities Jenny Craig Novartis Medical Nutrition Gerber Date August 2006 July 2007 Sept 2007 Price USD 600 m 2.5 bn 5.5 bn Sales 1.4x 2.6x 2.8x EBITDA n/a 17.6x 15.7x *weighted by purchase price Average* sales multiple 2.6x 14

Jenny Craig - August 2006 Adding a fourth Business Unit, Weight Management, a focus growth area for Nestlé Nutrition + Proven and effective weight management direct-to-consumer model Sustainable weight loss with food, body, mind solution - delivered through 1-1 counselling Retention of experienced management team 15

Jenny Craig Business Model Marketing Call to action: 1-800-JENNY-20 Contact with Jenny Craig Enrolled in a Jenny Craig centre or Jenny Direct YourStyle Profile Counselling & menu plan Ongoing weekly visits: Lose weight & keep it off 16

Jenny Craig Financial Update Strong sales growth continuing in 2008 Sales (USD m) 600 500 400 300 200 100 409 492 558 0 2005 2006 2007 EBIT margins lifted from high single-digit to mid double-digit Very strong start in 2008 with significant increase in consumer leads following new campaigns 17

Novartis Medical Nutrition - July 2007 Adding CHF 1.2 bn to our CHF 0.8 bn HealthCare Nutrition business + Now strong No. 2 in global healthcare nutrition market with potential for global leadership Strengthening benefit platforms, e.g. cancer, critical care and ageing Complementary set of capabilities and pipelines 18

Novartis Medical Nutrition Integration highlights Integration has gone very well and is on track The organisation is now in place - one face to the customers and a single sales force in all countries Aligned R&D organisation and creation of aligned global marketing organisation to accelerate growth Duplicate functions between both companies eliminated Key markets moved into GLOBE (US in Q3 08) and shared services established with relevant Nestlé functions Divestments of Spain and France completed 19

Novartis Medical Nutrition Financial update Combined business exceeded expectations for 2007 Cost synergies in line with acquisition plan (projected at 5% for Year 3) and on track Double-digit sales growth Canada, Brazil, Spain, UK - very strong single digit growth in Japan, France, Italy US performing in line with expectations despite challenging economic environment 20

A Global Leadership Team well balanced between both companies Global Business Head Regional Business Head, NA Regional Business Head, LATAM Regional Business Head, Europe Regional Business Head, AOA Head of Marketing Head of Sales Development Head of R&D Head of Operations Head of Finance & Control Head of Legal & New Business Development Head of Communications Head of Human Resources Nestlé Novartis 21

HealthCare Nutrition Global Presence HealthCare Nutrition - Facts & figures Sales: CHF 2.0 billion in 2008 Present in 30 markets, organized in four regions Employees: 2500 HQ in Gland (CH) EUR 33% of sales NAM 50% of sales LATAM 5% of sales AOA 12% of sales 22

Gerber - September 2007 Adding > CHF 2.3 bn to our Infant Nutrition business + Iconic brand in US Category leadership in all key accounts Deep consumer understanding Unique consumer & competitive research capabilities 23

Gerber Integration highlights Phase 1 : Early Stabilization projects complete Global HQ locations are established Strong management team represents the best of both ; Gerber management leads US, Mexico & Poland (3 largest Gerber markets) Phase 2 : Fully Operational implementation on track Migration of infrastructure & IT Sales & distribution alignment single face to the customer R&D alignment Global R&D Centre established for Infant Meals & Drinks in Fremont, Michigan Similar cultures ease transition Science, Health & Wellness are the foundation Consumer-centric innovation is the key driver 24

Gerber Financial update Cost synergies on track Full potential to be realised after GLOBE implementation US sales growth maintained despite challenging economic environment Other markets show strong growth: Mexico: over 20% sales growth YTD Poland: double digit sales growth Russia: growing very rapidly off a small base, aided by strong penetration of Gerber range 25

Global Infant Nutrition incl. Gerber 2006 Sales CHF 4.8 bn 2008 est. Sales CHF 8.0 bn Meals & Drinks 15% CHF 0.7 bn Cereals +GUMs 27% CHF 1.3 bn Infant Formula 58% CHF 2.8 bn Meals & Drinks 27% CHF 2.2 bn Gerber Life 6% CHF 0.5 bn Cereals, GUMs & Care 24% CHF 1.9 bn Infant Formula 43% CHF 3.5 bn 26

Nestlé Nutrition Update Conclusion Good progress against our 3 stated objectives for 2008 The base business is performing strongly with a good start in 2008 10/20 remains our mid-term objective The integrations are going very well - in line with/above our original acquisition plans We continue our relentless pursuit of innovation to accelerate growth and are the spearhead of Nestlé s transformation to The world's leading Nutrition, Health & Wellness company 27

Nestlé Investor Seminar 2008 28